title: Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage.
abstract: Because of the critical role of the DNA topoisomerases in the synthesis and conformation of DNA, and the well-known observation that radiation inhibits replicative DNA synthesis, we have examined the possibility that inhibitors of these enzymes might influence radiation lethality. In particular, using protocols involving the administration of either fresh or conditioned medium, we examined the ability of intercalative and nonintercalative inhibitors to affect the expression of potentially lethal damage and/or sublethal damage. The inhibitors examined were amsacrine, teniposide, etoposide, and novobiocin; only the latter compound was clearly effective in a selective way at nontoxic concentrations, and this was observed specifically in reference to the repair of potentially lethal damage effected by incubation in conditioned medium. These results are another example of differences between the repair of sublethal versus potentially lethal damage that further support distinctions between the two. At a mechanistic level, these and other data suggest that the property of novobiocin that is relevant in the foregoing is its metabolic inhibition of replicative DNA synthesis, a process which may be more important in the repair of potentially lethal damage as opposed to sublethal damage.
authors.affiliation: Radioation Biology Center, Kyoto University, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Utsumi
authors.forename: M L
authors.initials: ML
authors.lastname: Shibuya
authors.forename: M M
authors.initials: MM
authors.lastname: Elkind
mesh_terms: D000677:Amsacrine / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D004249:DNA Damage; D004260:DNA Repair / Q000187:drug effects*; D005047:Etoposide / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology*; D013713:Teniposide / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors
chemical_list: D059005:Topoisomerase II Inhibitors; D000677:Amsacrine; D009675:Novobiocin; D005047:Etoposide; D013713:Teniposide